Wall Street Remains Bullish on Olema Pharmaceuticals Inc. (OLMA)
The update comes as part of the firm’s assumption of coverage on 22 biotech firms that have a market capitalization between $300 million and $10 billion.
Olema Pharmaceuticals Inc. (OLMA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 5,295,893 | $51,846,792 | 2.1% | |
| 2. | Deep Track Capital David Kroin | 3,470,172 | $33,972,984 | +1% | 0.95% |
| 3. | Logos Capital Arsani William | 3,208,875 | $31,414,886 | 2.82% | |
| 4. | Woodline Partners Michael Rockefeller And Karl Kroeker | 2,217,893 | $21,713,172 | -37% | 0.1% |
| 5. | Vivo Capital Albert Cha And Frank Kung | 1,505,862 | $14,742,389 | 1.19% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.76 | 300,000 | $1,727,370.00 | 7,800,000 | 2025-01-08 | Filing | |
| $6.75 | 700,761 | $4,730,136.75 | 700,761 | 2024-12-13 | Filing | |
| $6.75 | 700,761 | $4,730,136.75 | 1,408,875 | 2024-12-17 | Filing | |
| $13.09 | 50,000 | $654,250.00 | 1,800,000 | 2023-12-05 | Filing | |
| $14.95 | 50,000 | $747,480.00 | 1,750,000 | 2023-12-05 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.12 | 3,489 | $101,599.68 | 737,770 | 2026-01-14 | Filing | |
| $28.73 | 100,000 | $2,873,000.00 | 139,727 | 2026-01-15 | Filing | |
| $28.01 | 3,822 | $107,054.22 | 239,727 | 2026-01-13 | Filing | |
| $28.99 | 35,003 | $1,014,736.97 | 542,761 | 2026-01-14 | Filing | |
| $28.60 | 14,997 | $428,914.20 | 577,764 | 2026-01-14 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 447,046 | $11,176,150 | 0.39% | |
| 2. | 44,505 | $1,112,625 | 0.09% | |
| 3. | 3,764 | $94,100 | 0% | |
| 4. | 1,178 | $29,450 | 0% | |
| 5. | 723 | $18,075 | 0% |
News See All
14 Best Booming Stocks to Buy Right Now
In a report released on January 9, Goldman Sachs said that it expects the index to rally 12% in 2026.
Olema (OLMA) Hits 4-Year High as Jefferies Hikes PT
The upgrade reflected the investment firm’s confidence in oral Selective Estrogen Receptor Degrader (SERD), supported by Roche’s encouraging results from the phase 3 trial of giredestrant in the treatment...
Guggenheim Initiates Olema Pharmaceuticals (OLMA) Coverage with Buy Rating and $20 PT, Cites Palazestrant Potential
Olema Pharmaceuticals Inc. (NASDAQ:OLMA) is one of the best hot stocks to invest in. On October 8, Guggenheim initiated coverage of Olema Oncology with a Buy rating and $20 price target.
12 Best Hot Stocks to Invest In
On September 24, Ryan Detrick, Carson Group chief market strategist, joined CNBC's 'Power Lunch' to discuss why he still expects a strong end-of-year rally.
Goldman Sachs Raises Stake in Olema Pharmaceuticals, Inc. (OLMA)
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) is among the best fast money stocks to buy now. During the first quarter, Goldman Sachs Group Inc. expanded its holdings in Olema Pharmaceuticals, Inc.
11 Best Fast Money Stocks to Buy Now
In this fast-paced world, most people have become impatient. Everyone is drawn to whatever delivers quick results, whether it be fast fame or fast money.
Clinical Trial Progress and Analyst Endorsement Spark Short-Term Rebound for Olema Pharmaceuticals
Headquartered in California, Olema Pharmaceuticals, Inc.
11 Best Short-Term Stocks to Invest in
The latter half of the 2025 market is caught between conflicting signals.
H.C. Wainwright Backs Olema Pharmaceuticals (OLMA) as Phase 3 Trials Advance
On May 28, Olema Pharmaceuticals, Inc.
Hedge Fund Resource Center Billionaire Hedge Funds
